BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26567750)

  • 21. Damage-associated molecular patterns in cancer: a double-edged sword.
    Hernandez C; Huebener P; Schwabe RF
    Oncogene; 2016 Nov; 35(46):5931-5941. PubMed ID: 27086930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered fusion hybrid vaccine of IL-18 gene-modified tumor cells and dendritic cells induces enhanced antitumor immunity.
    Xia D; Li F; Xiang J
    Cancer Biother Radiopharm; 2004 Jun; 19(3):322-30. PubMed ID: 15285878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1.
    Birger Y; Catez F; Furusawa T; Lim JH; Prymakowska-Bosak M; West KL; Postnikov YV; Haines DC; Bustin M
    Cancer Res; 2005 Aug; 65(15):6711-8. PubMed ID: 16061652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular Alarmins: Hidden dangers signals crucial for cancer, host defense and inflammatory processes.
    Joosten LAB; Netea MG
    Semin Immunol; 2018 Aug; 38():1-2. PubMed ID: 30554607
    [No Abstract]   [Full Text] [Related]  

  • 25. Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment.
    Vasaturo A; Verdoes M; de Vries J; Torensma R; Figdor CG
    Immunobiology; 2015 Feb; 220(2):243-8. PubMed ID: 25466585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunological aspects of anticancer chemotherapy].
    Zitvogel L; Tesniere A; Apetoh L; Ghiringhelli F; Kroemer G
    Bull Acad Natl Med; 2008 Oct; 192(7):1469-87; discussion 1487-9. PubMed ID: 19445369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.
    Hokey DA; Larregina AT; Erdos G; Watkins SC; Falo LD
    Cancer Res; 2005 Nov; 65(21):10059-67. PubMed ID: 16267032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive metabolomics identifies the alarmin uric acid as a critical signal for the induction of peanut allergy.
    Kong J; Chalcraft K; Mandur TS; Jimenez-Saiz R; Walker TD; Goncharova S; Gordon ME; Naji L; Flader K; Larché M; Chu DK; Waserman S; McCarry B; Jordana M
    Allergy; 2015 May; 70(5):495-505. PubMed ID: 25647422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR2- and 4-independent immunomodulatory effect of high molecular weight components from Ascaris suum.
    Favoretto BC; Silva SR; Jacysyn JF; Câmara NO; Faquim-Mauro EL
    Mol Immunol; 2014 Mar; 58(1):17-26. PubMed ID: 24263181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CTLA-4 blockade enhances antitumor immunity of intratumoral injection of immature dendritic cells into irradiated tumor in a mouse colon cancer model.
    Son CH; Bae JH; Shin DY; Lee HR; Choi YJ; Jo WS; Ho Jung M; Kang CD; Yang K; Park YS
    J Immunother; 2014 Jan; 37(1):1-7. PubMed ID: 24316550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal Stromal Cells Prevent Allostimulation In Vivo and Control Checkpoints of Th1 Priming: Migration of Human DC to Lymph Nodes and NK Cell Activation.
    Consentius C; Akyüz L; Schmidt-Lucke JA; Tschöpe C; Pinzur L; Ofir R; Reinke P; Volk HD; Juelke K
    Stem Cells; 2015 Oct; 33(10):3087-99. PubMed ID: 26184374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage inflammatory protein derivative ECI301 enhances the alarmin-associated abscopal benefits of tumor radiotherapy.
    Kanegasaki S; Matsushima K; Shiraishi K; Nakagawa K; Tsuchiya T
    Cancer Res; 2014 Sep; 74(18):5070-8. PubMed ID: 25038226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Third generation dendritic cell vaccines for tumor immunotherapy.
    Frankenberger B; Schendel DJ
    Eur J Cell Biol; 2012 Jan; 91(1):53-8. PubMed ID: 21439674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The GAR/RGG motif defines a family of nuclear alarmins.
    Wu S; Teo BHD; Wee SYK; Chen J; Lu J
    Cell Death Dis; 2021 May; 12(5):477. PubMed ID: 33980825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor signaling in anti-cancer immunity.
    Okamoto M; Sato M
    J Med Invest; 2003 Feb; 50(1-2):9-24. PubMed ID: 12630564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs.
    Wang D; Li Y; Yu D; Song SS; Kandimalla ER; Agrawal S
    Int J Oncol; 2004 Apr; 24(4):901-8. PubMed ID: 15010828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innate immunity in DNA vaccine with Toxoplasma gondii-heat shock protein 70 gene that induces DC activation and Th1 polarization.
    Makino M; Uemura N; Moroda M; Kikumura A; Piao LX; Mohamed RM; Aosai F
    Vaccine; 2011 Feb; 29(10):1899-905. PubMed ID: 21236236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses.
    Ning Y; Xu D; Zhang X; Bai Y; Ding J; Feng T; Wang S; Xu N; Qian K; Wang Y; Qi C
    Int J Cancer; 2016 Jun; 138(11):2713-23. PubMed ID: 26773960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-4 blocks TH1-polarizing/inflammatory cytokine gene expression during monocyte-derived dendritic cell differentiation through histone hypoacetylation.
    López-Bravo M; Minguito de la Escalera M; Domínguez PM; González-Cintado L; del Fresno C; Martín P; Martínez del Hoyo G; Ardavín C
    J Allergy Clin Immunol; 2013 Dec; 132(6):1409-19. PubMed ID: 24139608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential of Toll-like receptor 9 agonists in combined anticancer immunotherapy strategies: synergy of PAMPs and DAMPs?
    Holtick U; Klein-Gonzalez N; von Bergwelt-Baildon MS
    Immunotherapy; 2011 Mar; 3(3):301-4. PubMed ID: 21395370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.